Challenges

Experts share their insights in diagnosing and managing rare conditions
Thyroid Eye Disease: Incidence and Treatment

Thyroid Eye Disease: Incidence and Treatment

Gary Joseph Lelli, MD, of the Department of Ophthalmology at Weill Cornell Medicine talks about the incidence and treatment options for thyroid eye disease due to Graves’ disease.

Thyroid Eye Disease: Diagnosis and Symptoms

Thyroid Eye Disease: Diagnosis and Symptoms

Gary Joseph Lelli, MD, of the Department of Ophthalmology at Weill Cornell Medicine talks about thyroid eye disease due to Graves’ disease, including which clinicians are most likely to diagnose this condition and the most common symptoms in this highly variable rare condition.

FDA Approves Landmark New Therapy for Cystic Fibrosis

FDA Approves Landmark New Therapy for Cystic Fibrosis

The U.S. Food and Drug Administration has approved Vertex’s Trikafta (elexacaftor/ tezacaftor/ ivacaftor and ivacaftor) for the treating persons, 12 years and older, with cystic fibrosis who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Hemophilia Explained

Hemophilia Explained

Joe Pugliese of the Hemophilia Alliance, a not-for-profit organization of federally funded hemophilia treatment centers that is working to ensure its member have the expertise, resources and public support to sustain their integrated clinical and pharmacy services for persons with hemophilia and other bleeding disorders.

  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.